VYGR Voyager Therapeutics Inc
Company Analysis
Latest News
🟢 Voyager Therapeutics is trading 5% up in pre-market
Voyager Therapeutics is trading 5.23% up in pre-market at $2.39 on October 13, with no clearly confirmed company-specific announcement explaining the move. -...
🟢 Voyager Therapeutics rises 5.7% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Voyager Therapeutics is trading 5% down amid biotech sector weakness
Voyager Therapeutics is trading at $2.35, down 5.06%, amid biotech sector pressure. - The provided sector context reports XBI down 2.04%, pointing to sector...
🔴 Voyager Therapeutics is trading 5% down
Voyager Therapeutics is trading 5.05% down now at $2.54, with no company-specific announcement or catalyst identified in available news and company release...
🟢 Voyager Therapeutics is trading 6.69% up in after-hours trading with no clear catalyst identified
Voyager Therapeutics is trading 6.69% higher at $2.86, with no clear catalyst identified for the after-hours move. - Shares closed at $2.68 on September 25,...
🔴 Voyager Therapeutics is trading 5% down today as yields and oil concerns pressure biotech valuations
Voyager Therapeutics is trading at $2.66, down 5.00%, as continued pressure on biotechnology and growth stocks weighs on the shares. - Elevated Treasury...
🔴 Voyager Therapeutics is trading 5.4% down today as risk-off trading pressures biotech stocks
Voyager Therapeutics is trading 5.4% down now at $2.71 after broader risk-off trading pressured biotechnology and growth stocks. - The decline appears tied...
🔴 Voyager Therapeutics is trading 5.4% down today as crude and Treasury yields pressure risk appetite
Voyager Therapeutics is trading 5.4% lower at $2.97 amid broader market weakness, as rising crude oil and Treasury yields pressure risk appetite. - The Nasdaq...
🔴 Voyager Therapeutics is trading 5.15% down today, below its September 8 close
Voyager Therapeutics is trading 5.15% down at $3.23, reversing its premarket gain and falling below its September 8 close of $3.40. - The company presented at...
🟢 Voyager Therapeutics is trading 5.88% up in pre-market
Voyager Therapeutics is trading 5.88% up at $3.60 in pre-market after closing at $3.40 on September 8, 2026; no specific catalyst has been identified. - The...
🔴 Voyager Therapeutics is trading 5% down today with no clear catalyst identified
Voyager Therapeutics is trading at $3.36 (-5.08%) with no clear company-specific catalyst identified. - No major announcement dated September 3, 2026, was...
🔴 Voyager Therapeutics is trading 5.23% down today after no clear company-specific announcement was identified
Voyager Therapeutics is trading 5.23% down now at $3.35, after no clear company-specific announcement was identified for August 31, 2026. - The...
🟢 Voyager Therapeutics is trading 5.78% up today in pre-market
Voyager Therapeutics is trading 5.78% up at $3.66, with no clear company-specific catalyst identified for August 28, 2026. - Latest identifiable company...
🔴 Voyager Therapeutics falls 5.4% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Voyager Therapeutics rises 5.5% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🔴 Voyager Therapeutics is trading 5.36% down in pre-market
Voyager Therapeutics is trading 5.36% down at $3.00, versus its August 10 closing price of $3.17; no clear overnight catalyst was identified. - No new August...
Voyager Therapeutics second quarter 2026 loss narrows to $0.40 per share with $149M cash
Voyager Therapeutics reported a narrowed net loss of $24.5 million for the second quarter of 2026, primarily driven by a 30% reduction in research and...
Voyager Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Voyager Therapeutics is expected to report Q2 2026 revenue of $4.52 million and an EPS loss of $0.55, with its $3.12 share price currently trading...
🟢 Voyager Therapeutics is trading 5.2% up today in a pre-market rebound with no clear catalyst
Voyager Therapeutics is trading at $3.25 (5.2% up) in pre-market, rebounding from several mixed sessions over the past week despite a lack of fresh...
🟢 Voyager Therapeutics is trading 5.25% up today amid broader biotech sector strength
Voyager Therapeutics is trading at $3.21 (+5.25%) in pre-market sessions as the stock gains momentum despite a lack of fresh company-specific announcements. •...